Provided by Tiger Trade Technology Pte. Ltd.

Piper Sandler Companies

75.06
-0.5500-0.73%
Post-market: 75.060.00000.00%19:30 EDT
Volume:839.34K
Turnover:63.07M
Market Cap:5.30B
PE:17.40
High:75.64
Open:75.35
Low:74.71
Close:75.61
52wk High:95.07
52wk Low:68.70
Shares:70.67M
Float Shares:67.48M
Volume Ratio:1.92
T/O Rate:1.24%
Dividend:0.73
Dividend Rate:0.97%
EPS(TTM):4.31
EPS(LYR):3.96
ROE:24.53%
ROA:16.98%
PB:3.86
PE(LYR):18.98

Loading ...

Southern First Bancshares launches underwritten public offering of common stock

Reuters
·
Apr 16

Pelthos CEO to hold investor meetings at Piper Sandler Spring Biopharma Symposium

Reuters
·
Apr 14

Goldman Sachs Keeps Their Buy Rating on Piper Sandler (PIPR)

TIPRANKS
·
Apr 14

BUZZ-Replimune slumps after FDA drug rejection prompts downgrades

Reuters
·
Apr 13

Viking Therapeutics to attend Raymond James Biotech/BioPharma Conference in investor meetings

Reuters
·
Apr 10

Kontoor Brands names Erinn Murphy VP, global head of finance and operations at Helly Hansen

Reuters
·
Apr 09

Piper Sandler announces annual shareholder meeting via webcast

Reuters
·
Apr 09

Collegium Pharma to present at Needham Virtual Healthcare Conference

Reuters
·
Apr 08

Perma-Pipe names Nancy Zakhour to board, adds CEO Saleh Sagr as director

Reuters
·
Apr 07

Inovio plans underwritten stock offering with Series A and B warrants

Reuters
·
Apr 06

InspireMD inks BTIG equity distribution deal for up to $75 million ATM offering

Reuters
·
Apr 04

A Look At Piper Sandler (PIPR) Valuation After Four For One Stock Split Takes Effect

Simply Wall St.
·
Apr 03

Inovio prices USD 17.5 million follow-on equity offering at USD 1.40 per share

Reuters
·
Apr 02

Inovio plans underwritten public offering of common stock with Series A and B warrants

Reuters
·
Apr 02

BUZZ-Baker Hughes venture HMH on track for muted Nasdaq debut

Reuters
·
Apr 01

HMH Holding raises over $210 million in US IPO

Reuters
·
Apr 01

BUZZ-Wall Street bullish on MiniMed after $560 million IPO

Reuters
·
Apr 01

Werewolf Therapeutics FY2025 net loss narrows 13.76% to $61 million; cash and cash equivalents drop 48.6% to $57 million

Reuters
·
Mar 27

BUZZ-Morgan Stanley bullish on Generate Biomedicines, cites strength of lead asthma drug

Reuters
·
Mar 26

S&P 500 Futures Decline In Premarket Trading; Piper Sandler, Intercorp Finl Svcs Lead

Dow Jones
·
Mar 24